UMB Bank’s Novavax NVAX Stock Holding History

UMB Bank’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-25	Closed	-$317	–	2179
2024 Q2	$317	Buy	+25	New	+$252	﹤0.01%	2105
2022 Q3	–	Sell	-134	Closed	-$7K	–	1905
2022 Q2	$7K	Hold	134	–	–	﹤0.01%	1501
2022 Q1	$10K	Sell	134 -7	-5%	-$624	﹤0.01%	1489
2021 Q4	$20K	Buy	+141	New	+$24.2K	﹤0.01%	1278

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

UMB Bank's NVAX Position: Q3 2024 in Review

UMB Bank sold out of Novavax (NVAX) in Q3 2024, closing a stake of 25 shares — an estimated $317 sold.

UMB Bank first reported a position in NVAX in Q4 2021 and held it in 4 quarters. The position peaked at $20K in Q4 2021. 237 funds tracked by Wall St. Rank hold NVAX as of Q3 2024.

UMB Bank reported no remaining Novavax position as of Q3 2024 after selling out during the quarter.
UMB Bank sold 25 Novavax shares in Q3 2024, an estimated $317.
UMB Bank first reported a position in Novavax in Q4 2021 and held it in 4 quarters.
UMB Bank's Novavax position peaked at $20K in Q4 2021.
237 funds tracked by Wall St. Rank held Novavax as of Q3 2024.

Based on UMB Bank's 13F filing for Q3 2024, filed 9 Oct 2024.